Alexandra Andrews - Neurotech International Chief Officer
| NTI Stock | 0.07 0 1.45% |
Executive
Alexandra Andrews is Chief Officer of Neurotech International
| Address | 145 Stirling Highway, Nedlands, WA, Australia, 6009 |
| Phone | 61 8 9389 3130 |
| Web | https://www.neurotechinternational.com |
Neurotech International Management Efficiency
The company has return on total asset (ROA) of (0.3729) % which means that it has lost $0.3729 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6392) %, meaning that it generated substantial loss on money invested by shareholders. Neurotech International's management efficiency ratios could be used to measure how well Neurotech International manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Neurotech International's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 12.8 M in 2024, whereas Non Current Liabilities Total is likely to drop 0.00 in 2024.Similar Executives
| Found 7 records | EXECUTIVE Age | ||
| Jinal Shah | Zip Co Limited | N/A | |
| Alex Christie | Zip Co Limited | N/A | |
| Sarah Brown | Zip Co Limited | N/A | |
| David Tyler | Zip Co Limited | N/A | |
| Gordon Bell | Zip Co Limited | N/A | |
| Joe Heck | Zip Co Limited | N/A | |
| Andy Stearns | Zip Co Limited | N/A | |
Management Performance
| Return On Equity | -0.64 | ||||
| Return On Asset | -0.37 |
Neurotech International Leadership Team
Elected by the shareholders, the Neurotech International's board of directors comprises two types of representatives: Neurotech International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Neurotech. The board's role is to monitor Neurotech International's management team and ensure that shareholders' interests are well served. Neurotech International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Neurotech International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emanuela Russo, Chief Board | ||
| Alessandra Gauvin, Joint Secretary | ||
| Alexandra Andrews, Chief Officer | ||
| Peter BSc, Chief Ltd | ||
| AO AO, Chief Director | ||
| Associate Ellaway, Chief Officer | ||
| ACIS ACIS, Company Sec | ||
| Thomas MBA, Executive Director | ||
| Gerald Quigley, Director Director |
Neurotech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Neurotech International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.64 | ||||
| Return On Asset | -0.37 | ||||
| Profit Margin | (1.60) % | ||||
| Operating Margin | 135.32 % | ||||
| Current Valuation | 60.8 M | ||||
| Shares Outstanding | 1.03 B | ||||
| Shares Owned By Insiders | 33.64 % | ||||
| Shares Owned By Institutions | 2.23 % | ||||
| Price To Book | 6.09 X | ||||
| Price To Sales | 22.79 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Neurotech Stock Analysis
When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.